BI
VIGL

BVF Inc’s Vigil Neuroscience VIGL Stock Holding History

BVF Inc’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,013,633
Closed -$7.14M – 52
2025
Q1 		$7.14M Buy
4,013,633
+2,200,000
+121% +$4.94M 0.29% 37
2024
Q4 		$3.08M Hold
1,813,633
– – 0.1% 47
2024
Q3 		$6.17M Hold
1,813,633
– – 0.18% 40
2024
Q2 		$7.25M Hold
1,813,633
– – 0.2% 40
2024
Q1 		$6.18M Hold
1,813,633
– – 0.17% 45
2023
Q4 		$6.13M Hold
1,813,633
– – 0.15% 53
2023
Q3 		$9.78M Hold
1,813,633
– – 0.26% 46
2023
Q2 		$17M Hold
1,813,633
– – 0.48% 37
2023
Q1 		$17.8M Hold
1,813,633
– – 0.65% 41
2022
Q4 		$22.7M Hold
1,813,633
– – 0.96% 33
2022
Q3 		$16.5M Buy
+1,813,633
New +$13.3M 0.68% 44

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

BVF Inc's VIGL Position: Q2 2025 in Review

BVF Inc sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 4,013,633 shares — an estimated $7.14M sold.

BVF Inc first reported a position in VIGL in Q3 2022 and held it in 11 quarters. The position peaked at $22.7M in Q4 2022. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

  • BVF Inc reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
  • BVF Inc sold 4,013,633 Vigil Neuroscience shares in Q2 2025, an estimated $7.14M.
  • BVF Inc first reported a position in Vigil Neuroscience in Q3 2022 and held it in 11 quarters.
  • BVF Inc's Vigil Neuroscience position peaked at $22.7M in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on BVF Inc's 13F filing for Q2 2025, filed 14 Aug 2025.